Market open

UCB/€UCB

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About UCB

UCB SA, founded in 1928, is a global biopharmaceutical company headquartered in Brussels, Belgium. The company specializes in the research, development, and commercialization of innovative therapies primarily for the treatment of neurological and immunological disorders. Operating in the healthcare sector, UCB is dedicated to advancing science and addressing unmet medical needs for patients worldwide.

Ticker

€UCB

Trading on

BSE

Industry

Pharmaceuticals
Headquarters

Employees

9,215

ISIN

BE0003739530

UCB Metrics

BasicAdvanced
€29B
27.15
€5.61
0.34
€0.97
0.64%
€29B
0.34
€198.95
€118.10
354K
€0.97
1.357
0.871
29.544
30.172
24.32%
5.19%
3.18%
11.21%
27.153
4.701
2.87
59.42
31.43
0.64%
0.64%
18.72%
218.48%
2.12%
0.91%
2.26%

What the Analysts think about UCB

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for UCB stock.

UCB Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

UCB Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €UCB

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for UCB stock?

What is the P/E ratio for UCB stock?

Does UCB stock pay dividends?

When is the next UCB dividend payment date?

What is the beta indicator for UCB?